Company Quick10K Filing
Semler Scientific
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-03-09
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-03
10-K 2018-12-31 Filed 2019-03-07
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-03
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-08
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-17
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-03
10-Q 2015-06-30 Filed 2015-08-04
10-K 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-11-03
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-01
10-Q 2013-03-31 Filed 2015-05-04
8-K 2020-08-13 Officers
8-K 2020-08-03 Earnings, Exhibits
8-K 2020-05-04
8-K 2020-03-03
8-K 2019-11-06
8-K 2019-10-30
8-K 2019-10-02
8-K 2019-07-26
8-K 2019-05-03
8-K 2019-04-29
8-K 2019-02-27
8-K 2018-10-26
8-K 2018-10-04
8-K 2018-10-02
8-K 2018-07-31
8-K 2018-05-01
8-K 2018-02-28

Semler Scientific Financials

SMLR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Alfacourse (ALFA) 407,519 -40,331.9 -303% 5 19 0 0 -14 -10 407,514
ETFS Silver Trust (SIVR) 406,944 10.5 10% 394,201 97 0 0 38,813 38,813 406,944
Farmers Capital Bank (FFKT) 402,755 8.9 0% 10,900,000 1,434,070 0 0 15,694 34,787 309,509
Keryx Biopharmaceuticals (KERX) 402,246 0% -4.1 -60% 151,784 206,003 94,218 0 -90,838 -90,648 376,100
TCR2 Therapeutics (TCRR) 399,387 -10.2 -19% 179,511 8,357 0 0 -34,772 -34,214 349,653
Hennessy Capital Acquisition III (HCAC) 381,265 0% -35.1 -18% 421,802 475,144 431,588 0 -74,570 -21,261 746,662
Charter Financial (CHFN) 381,167 7.4 1% 1,625,835 1,401,429 0 0 16,852 35,949 265,269
Invesco DB Agriculture Fund (DBA) 380,908 -13.2 -7% 384,159 253 0 0 -28,794 -28,769 380,908
Karuna Therapeutics (KRTX) 379,989 -9.0 -15% 164,227 1,697 0 0 -24,178 -24,163 218,389
Semler Scientific (SMLR) 365,490 88% 43.9 65% 18,857 4,755 23,616 20,861 12,252 8,128 356,948
Gulfmark Offshore (GLF) 354,229 0% 26.1 -6% 417,402 135,430 78,633 0 -27,052 15,946 416,697
PHH (PHH) 354,128 0% -0.2 -10% 1,442,000 953,000 315,000 0 -138,000 -149,000 37,128
Harpoon Therapeutics (HARP) 349,762 0% -5.8 -29% 142,388 35,157 4,606 0 -41,304 -39,604 228,562
Government Properties Income Trust (GOV) 349,491 0% 1.1 -1% 4,360,249 2,693,636 343,443 0 -34,694 297,616 316,458
JEM Capital (JEM) 345,932 -17,698.3 0 115 0 0 -20 -20 345,931
Fellazo (FLLZ) 345,056 -1,969.0 -849% 21 680 0 0 -175 -175 345,056
Castle Biosciences (CSTL) 334,822 85% 35.2 4% 113,200 30,864 25,513 21,812 4,580 7,539 265,251
New York & Company (NWY) 330,180 29% -12.5 -4% 486,431 430,014 850,241 249,177 -21,388 -21,254 264,615
Invesco DB US Dollar Index Bullish Fund (UUP) 329,522 16.0 6% 330,667 203 0 0 20,586 20,596 329,522
Zynex (ZYXI) 324,063 62% 25.1 37% 24,724 8,332 40,647 25,317 9,167 12,416 312,129

Balance Sheet ($'000)2013-03-312014-03-312014-06-302014-09-302014-12-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3,0617,6126,5545,9734,1562,3401,9254051,4411,0225176221594965781,4574192,0093,0873,2844,5444,1828,542
Accounts Receivable3561571273113552624391,2785996078978771,1818851,4771,3152,3771,8502,4802,8012,5333,5093,271
Inventory
PP&E26576948188542548557681760763772783322356427448457488520563
Assets6,4038,7417,6577,2277,5005,6783,5203,0793,4253,0612,9603,0723,1163,1553,8714,2384,2575,3127,0437,7199,0559,82418,857
Accounts Payable891391612178911661839390430281450310546647488341185251280257405669
Long-Term Debt1,0035441,8061,8631,66816600
Liabilities3,8081,8011,7492,6074,0643,9802,9894,1515,0865,5925,7665,9916,3546,7907,4596,8215,7815,0964,7313,5232,8943,6034,755
Stockholders' Equity2,5956,9405,9084,6203,4361,698531-1,072-1,661-2,531-2,806-2,919-3,238-3,635-3,588-2,583-1,5242162,3124,1966,1616,22114,102
Income Statement ($'000)2013-03-312014-03-312014-06-302014-09-302014-12-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,2028378468971,0551,3031,5622,9341,5011,6361,9822,3162,0552,5783,6074,2134,4635,4845,5796,7617,9538,902
Cost of Revenue2201551721781882443851,960417533398525540592724698704680615896885974
Gross Profit9826826747198671,0591,1779741,0841,1031,5841,7911,5151,9862,8833,5153,7594,8044,9645,8657,0687,928
R&D
SG&A2,0211,2431,2671,8241,8361,9662,4614,7261,7461,7911,6561,6661,8262,0662,3752,6542,5792,7802,8313,4423,7824,200
Tax0977-4,671
Net Income-1,372-817-1,032-1,466-1,200-1,341-1,580-4,208-1,006-966-362-220-871-850-412537061,4531,4681,8542,6197,779
Cash Flow ($'000)2013-03-312014-03-312014-06-302014-09-302014-12-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,503-1,026-868-366-1,562-919-69-1,644-1,093-447-366102-505435251440-3661,1431,7032,6804,710
Cash Investing-90-120-164-112-2,145-2161,727-425-71-250-234-259-402-201-183-182-92-210-456-386-366
Cash Financing4988,024-26-1031,890414-2,0735492,2002789526244410314621-58014513-2,65616